JP2005508892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508892A5 JP2005508892A5 JP2003521270A JP2003521270A JP2005508892A5 JP 2005508892 A5 JP2005508892 A5 JP 2005508892A5 JP 2003521270 A JP2003521270 A JP 2003521270A JP 2003521270 A JP2003521270 A JP 2003521270A JP 2005508892 A5 JP2005508892 A5 JP 2005508892A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- addiction
- vitamin
- deficiency
- starting material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000009472 formulation Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 206010012335 Dependence Diseases 0.000 claims 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 208000012237 paracetamol poisoning Diseases 0.000 claims 1
- 108010058237 plasma protein fraction Proteins 0.000 claims 1
- 229940081857 plasma protein fraction Drugs 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101217 | 2001-08-14 | ||
| PCT/DK2002/000531 WO2003016348A2 (en) | 2001-08-14 | 2002-08-12 | A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508892A JP2005508892A (ja) | 2005-04-07 |
| JP2005508892A5 true JP2005508892A5 (enExample) | 2006-01-05 |
Family
ID=8160667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003521270A Withdrawn JP2005508892A (ja) | 2001-08-14 | 2002-08-12 | Ｇｃ−グロブリンの大規模生産のための精製方法、これにより得られる物質およびそれらの医薬用途 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1419177B1 (enExample) |
| JP (1) | JP2005508892A (enExample) |
| AT (1) | ATE393780T1 (enExample) |
| AU (1) | AU2002321012B2 (enExample) |
| CA (1) | CA2456843A1 (enExample) |
| DE (1) | DE60226327T2 (enExample) |
| DK (1) | DK1419177T3 (enExample) |
| ES (1) | ES2305272T3 (enExample) |
| WO (1) | WO2003016348A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1778301A2 (en) * | 2004-06-29 | 2007-05-02 | Reliance Life Sciences Pvt., Ltd. | Process for improvement of virus-safe biological fluids |
| CN100354301C (zh) * | 2005-10-13 | 2007-12-12 | 南京工业大学 | 化学合成多肽的新型大规模分离制备技术 |
| US8129139B2 (en) | 2009-07-13 | 2012-03-06 | Allergan, Inc. | Process for obtaining botulinum neurotoxin |
| SG10201503899SA (en) * | 2010-05-18 | 2015-06-29 | Abbvie Inc | Apparatus And Process Of Purification Of Proteins |
| JP5860401B2 (ja) | 2010-09-03 | 2016-02-16 | 森田薬品工業株式会社 | 新規Ｇｃグロブリンガラクトース脱糖体の製造方法 |
| EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
| PL3081221T3 (pl) | 2013-12-13 | 2021-12-27 | Saisei Pharma Co., Ltd. | Kompozycja farmaceutyczna zawierająca produkt obróbki enzymatycznej siary bydlęcej |
| CN111632167B (zh) * | 2014-04-15 | 2021-12-28 | 勃林格殷格翰国际公司 | 在制造生物制品期间连续灭活病毒的方法、装置和系统 |
| PL3290043T3 (pl) * | 2015-06-01 | 2023-07-03 | Saisei Pharma Co., Ltd. | Produkt mleczny poddany obróbce enzymatycznej, sposób jego wytwarzania, kompozycja i produkt |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5177002A (en) * | 1989-11-20 | 1993-01-05 | Nobuto Yamamoto | In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor |
| ES2124702T3 (es) * | 1990-04-11 | 1999-02-16 | Brigham & Womens Hospital | Usos terapeuticos de compuestos que se unen a actina. |
| US6268478B1 (en) * | 1996-02-12 | 2001-07-31 | Cedars-Sinai Medical Center | Intracellular vitamin D binding protein |
-
2002
- 2002-08-12 CA CA002456843A patent/CA2456843A1/en not_active Abandoned
- 2002-08-12 AU AU2002321012A patent/AU2002321012B2/en not_active Ceased
- 2002-08-12 WO PCT/DK2002/000531 patent/WO2003016348A2/en not_active Ceased
- 2002-08-12 ES ES02754557T patent/ES2305272T3/es not_active Expired - Lifetime
- 2002-08-12 AT AT02754557T patent/ATE393780T1/de not_active IP Right Cessation
- 2002-08-12 DK DK02754557T patent/DK1419177T3/da active
- 2002-08-12 DE DE60226327T patent/DE60226327T2/de not_active Expired - Fee Related
- 2002-08-12 EP EP02754557A patent/EP1419177B1/en not_active Expired - Lifetime
- 2002-08-12 JP JP2003521270A patent/JP2005508892A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL378168A1 (pl) | Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków | |
| IL173204A0 (en) | Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments | |
| IS7814A (is) | Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum. | |
| AU2003293649A1 (en) | Novel xanthine derivatives, the production and the use thereof in the form of drugs | |
| IL212752A0 (en) | An molecule directed against the ??-secretase cleavage site of amyloid precursor protein, and uses thereof | |
| NO20020770L (no) | Anvendelse av monoaminoksidaseinhibitorer for fremstilling av legemidler egnet for behandling av obesitas | |
| ATE361279T1 (de) | N-[phenyl(piperidin-2-yl)methyl]benzamidderivat , verfahren zu ihrer herstellung und ihre therapeutische anwendung | |
| AU2003282094A1 (en) | Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments | |
| IL191926A0 (en) | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof | |
| WO2005010032A3 (en) | Replikin peptides and uses thereof | |
| EP1695699A4 (en) | MEDICINAL GRAINS AND THE GRAINS CONTAINING SOLID PREPARATIONS | |
| WO2003005880A3 (en) | Replikin peptides and uses thereof | |
| AU2003255612A1 (en) | Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments | |
| PL374420A1 (pl) | Proces wytwarzania kompozytu z kopolimeru blokowego i leku | |
| ITRM20030259A0 (it) | Catalizzatore multistrato, procedimento per la sua preparazione e suouso per l'ossidazione parziale di idrocarburi in fase gassosa. | |
| JP2004534810A5 (enExample) | ||
| JP2005517035A5 (enExample) | ||
| DE60230455D1 (de) | Natürliche verbindung für die behandlung von diabetes, deren herstellung und verwendung | |
| FR2870539B1 (fr) | Nouvelles methodes et medicaments | |
| EP1582589A4 (en) | PROTEIN COMPLEX, METHOD FOR THE PRODUCTION AND USE THEREOF | |
| JP2005523891A5 (enExample) | ||
| AU2003294952A1 (en) | 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same | |
| EP1411964A4 (en) | THE BLOOD GENERATING PEPTIDES AND THEIR USES | |
| IL173918A0 (en) | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same | |
| JP2004224775A5 (enExample) |